Search for: "United States v. Purify" Results 41 - 60 of 69
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Sep 2007, 1:04 pm
Purepac Pharma, Faulding, Watson Pharma, Danbury Pharma, Teva, Zenith Labs, Ivax, Apotex, Torpharm and Eon Labs) United States Court of Appeals for the Federal Circuit (06-1572). [read post]
7 Nov 2023, 10:09 am by Holly
Check carefully that both the FDA and the United States Patent and Trademark Office (USPTO) receive the same information. [read post]
22 Jul 2010, 11:07 am by Jason Rantanen
  Although as a practical matter this distinction may be of little value, as pharmaceutical companies often have production facilities located outside the United States, it is something to consider when seeking or opposing litigation under § 156. [read post]
21 Jan 2016, 8:43 pm by Steve Gottlieb
But on the floor a motion was made to make the point indisputable: “All persons born or naturalized in the United States, and subject to the jurisdiction thereof, are citizens of the United States and of the State wherein they reside. [read post]
1 Feb 2012, 8:50 pm
Additionally, both pre- and post- issuance opposition has long existed for United States trademarks. [read post]
1 Nov 2010, 7:56 am by Lawrence B. Ebert
But Dehmelt plainly did not invent the elemental unit of negative charge in the universe. [read post]
4 Feb 2015, 6:54 pm by Schachtman
Supp. 2d 1345, 1367 (S.D.Fla.2011), aff’d, Chapman v. [read post]
8 Aug 2012, 3:00 am by Terry Hart
” In March 1783, the US Continental Congress appointed a committee to “consider the most proper means of cherishing genius and useful arts through the United States by securing to authors or publishers of new books their property in such works. [read post]
11 Jun 2015, 2:11 pm by Robert Rouder (US)
The Caronia Effect For this reason, many observers saw the December 2012 decision in United States v. [read post]
4 Sep 2012, 7:09 am
It was for the legislature to change the law and the established practise of the USPTO (United States Patent and Trademark Office) if it wished to treat isolated DNA differently from other compositions of matter to account for its perceived special function. [read post]